Aeluma, Inc 8-K, filed Nov 12, 2026
Aeluma, Inc. (ALMU)
About this 8-K
Aeluma, Inc filed this 8-K on November 12, 2026.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
||
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition.
On November 12, 2026, Aeluma, Inc. issued a press release announcing its financial results for the first quarter ended September 30, 2026, which were disclosed in the Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 12, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information reported under this Item 2.02 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number |
Exhibit | |
| 99.1 | Press Release of Aeluma, Inc. dated November 12, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AELUMA, INC. | ||
| Date: November 12, 2026 | By: | /s/ Christopher Stewart |
| Christopher Stewart | ||
| Chief Financial Officer | ||
2
Exhibit 99.1
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Continued Progress in Technology Readiness for AI Datacom Market
Executed Purchase Agreement With Aixtron for MOCVD Capacity Expansion and Large-Diameter Wafer Manufacturing
GOLETA, CA – November 12, 2026 – Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a semiconductor company specializing in high-performance, scalable technologies for AI, mobile and consumer, defense and aerospace, and quantum, today reported financial results for its first quarter of fiscal 2027 ended September 30, 2026.
Fiscal First Quarter 2027 and Subsequent Highlights
| ● | Increased Technology Readiness: Advanced development of high-speed photodetectors and quantum dot lasers leveraging capabilities at Aeluma and supply chain partners such as Sumitomo Chemical Advanced Technologies. |
| ● | Manufacturing Expansion: Finalized a purchase agreement with Aixtron for a new 200 mm capable MOCVD system to expand manufacturing capacity and accelerate development for non-indium-phosphide photonics. |
| ● | Customer Engagements: Expanded customer discussions in Datacom and other markets regarding product opportunities and non-recurring engineering investments. Several initiatives involve potentially high-volume demand to support the 2028 through 2032 AI infrastructure buildout. |
| ● | CHIPS Funding: Continued diligence and definitive agreement negotiations with the U.S. Department of Commerce CHIPS R&D Office for up to $30 million in proposed funding for development and commercialization of photonics for AI and Advanced Computing. |
Management Commentary
“The current U.S. AI infrastructure buildout continues to progress and is expected to reach an aggregate investment of $10.3 trillion in 2032,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “The opportunities for photonics are vast, spanning scale-up and scale-out AI architectures in data centers.”
“Demand for photonic components includes lasers, modulators, photodetectors, and photonic integrated circuits or PICs. Supply chains are constrained, including indium phosphide substrate production and wafer fab capacity. Adopting proven strategies from consumer markets, Aeluma’s technology instead leverages gallium arsenide or silicon substrates, and existing fabs that are already qualified for large-volume markets.”
“As we progress through fiscal 2027, we remain focused on technology and product development for AI Datacom opportunities. Aeluma’s high-speed photodetectors and quantum dot lasers continue to attract customer attention. Our efforts include working with supply chain partners such as Sumitomo Chemical Advanced Technologies to ready technology in a production environment, and investment in MOCVD manufacturing capacity. Lastly, we continue to expand our customer discussions including negotiations on potential development investments and potentially large-volume product opportunities.”
Fiscal First Quarter 2027 Financial Results
| ● | Revenue was $0.6 million, compared with $1.4 million in the first quarter of fiscal 2026, generated primarily from R&D contracts. |
| ● | Net loss was $3.8 million, or ($0.19) per basic and diluted share, compared with a net loss of $1.5 million, or ($0.09) per basic and diluted share, for the same period last year. |
| ● | Adjusted EBITDA loss was $2.7 million, compared with an adjusted EBITDA loss of $0.4 million in the same period last year. |
| ● | Cash and cash equivalents totaled $53.9 million at September 30, 2026, compared with $56.0 million at June 30, 2026. |
Conference Call and Webcast
Aeluma will host a conference call at 2:00 p.m. Pacific Time and 5:00 p.m. Eastern Time on November 12, 2026 to discuss the Company’s financial results and business outlook. Interested participants may access the call by dialing (833) 890-6767 (domestic) or (412) 564-6155 (international) and referencing “Aeluma”.
A live webcast of the call will also be available on the “Investors” section of Aeluma’s website. The live webcast can also be accessed by clicking here. A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.
Annual Meeting of Stockholders
Aeluma’s 2026 Annual Meeting of Stockholders will be held virtually on November 19, 2026 at 9:00 a.m. Pacific Time. Stockholders of record as of September 23, 2026 are entitled to vote. Additional information regarding the Annual Meeting, including voting and virtual attendance instructions, is available in Aeluma’s definitive proxy statement filed with the SEC on September 30, 2026.
Note about Non-GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.
This press release includes non-GAAP financial measures, including:
| ● | Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses; and |
| ● | Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income. |
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.
2
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
About Aeluma, Inc.
Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.
Company:
Aeluma, Inc.
(805) 351-2707
info@aeluma.com
Investor Contact:
Financial Profiles, Inc.
Moira Conlon
(310) 622-8220
ir@aeluma.com
3
Aeluma, Inc. and Subsidiary
Condensed Consolidated Balance Sheets
| ($ in thousands) | September 30, (unaudited) | June 30, 2026 | ||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 53,875 | $ | 56,006 | ||||
| Accounts receivable | 504 | 340 | ||||||
| Prepaids and other current assets | 716 | 965 | ||||||
| Total current assets | 55,095 | 57,311 | ||||||
| Property and equipment: | ||||||||
| Equipment | 2,590 | 2,338 | ||||||
| Leasehold improvements | 547 | 547 | ||||||
| Accumulated depreciation | (1,598 | ) | (1,469 | ) | ||||
| Property and equipment, net | 1,539 | 1,416 | ||||||
| Right-of-use asset - operating | 1,868 | 1,916 | ||||||
| Other assets | 21 | 21 | ||||||
| Total assets | $ | 58,523 | $ | 60,664 | ||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 368 | $ | 341 | ||||
| Accrued expenses and other current liabilities | 1,502 | 1,369 | ||||||
| Lease liability - operating, current portion | 183 | 180 | ||||||
| Total current liabilities | 2,053 | 1,890 | ||||||
| Lease liability - operating, long-term portion | 1,795 | 1,842 | ||||||
| Total liabilities | 3,848 | 3,732 | ||||||
| Commitments and contingencies | - | - | ||||||
| Stockholders’ equity: | ||||||||
| Preferred stock | - | - | ||||||
| Common stock | 2 | 2 | ||||||
| Additional paid-in capital | 84,234 | 82,735 | ||||||
| Accumulated deficit | (29,561 | ) | (25,805 | ) | ||||
| Total stockholders’ equity | 54,675 | 56,932 | ||||||
| Total liabilities and stockholders’ equity | $ | 58,523 | $ | 60,664 | ||||
4
Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Operations (unaudited)
| Three Months Ended | ||||||||||||
| ($ in thousands, except per share data) | September 30, 2026 | June 30, 2026 | September 30, 2025 | |||||||||
| Revenue | $ | 568 | $ | 582 | $ | 1,385 | ||||||
| Operating expenses: | ||||||||||||
| Cost of revenue | 339 | 433 | 701 | |||||||||
| Research and development | 2,525 | 2,274 | 606 | |||||||||
| General and administrative | 1,952 | 2,247 | 1,686 | |||||||||
| Total operating expenses | 4,816 | 4,954 | 2,993 | |||||||||
| Loss from operations | (4,248 | ) | (4,372 | ) | (1,608 | ) | ||||||
| Other income: | ||||||||||||
| Interest income | 492 | 359 | 115 | |||||||||
| Total other income | 492 | 359 | 115 | |||||||||
| Loss before income tax expense | (3,756 | ) | (4,013 | ) | (1,493 | ) | ||||||
| Income tax expense | - | - | - | |||||||||
| Net loss | $ | (3,756 | ) | $ | (4,013 | ) | $ | (1,493 | ) | |||
| Net loss per share – basic and diluted | $ | (0.19 | ) | $ | (0.22 | ) | $ | (0.09 | ) | |||
| Weighted average common shares outstanding - basic and diluted | 19,270,622 | 18,603,331 | 16,141,153 | |||||||||
| Book value per share | $ | 2.84 | $ | 3.06 | $ | 2.53 | ||||||
5
Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows (unaudited)
| Three Months Ended September 30, | ||||||||
| ($ in thousands) | 2026 | 2025 | ||||||
| Operating activities: | ||||||||
| Net loss | $ | (3,756 | ) | $ | (1,493 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation expense | 1,376 | 1,056 | ||||||
| Depreciation and amortization expense | 130 | 102 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (164 | ) | (286 | ) | ||||
| Prepaids and other current assets | 249 | (196 | ) | |||||
| Other assets | (1 | ) | (8 | ) | ||||
| Accounts payable | 27 | (88 | ) | |||||
| Accrued expenses and other current liabilities | 393 | 98 | ||||||
| Net cash used in operating activities | (1,746 | ) | (815 | ) | ||||
| Investing activities: | ||||||||
| Purchase of equipment | (252 | ) | (210 | ) | ||||
| Net cash used in investing activities | (252 | ) | (210 | ) | ||||
| Financing activities: | ||||||||
| Proceeds from stock option exercise | 174 | 47 | ||||||
| Proceeds from public offering, net of offering costs | - | 23,385 | ||||||
| Payment for taxes related to net share settlement of stock options and restricted stock units | (307 | ) | - | |||||
| Net cash provided by (used in) financing activities | (133 | ) | 23,432 | |||||
| Net change in cash and cash equivalents | (2,131 | ) | 22,407 | |||||
| Cash and cash equivalents, beginning of period | 56,006 | 15,740 | ||||||
| Cash and cash equivalents, end of period | $ | 53,875 | $ | 38,147 | ||||
| Supplemental non-cash disclosures: | ||||||||
| Right-of-use asset - operating obtained in exchange for lease liability - operating | $ | - | $ | 274 | ||||
6
Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)
| Three Months Ended | ||||||||||||
| ($ in thousands, except per share data) | September 30, 2026 | June 30, 2026 | September 30, 2025 | |||||||||
| GAAP net loss | $ | (3,756 | ) | $ | (4,013 | ) | $ | (1,493 | ) | |||
| Non-GAAP adjustments: | ||||||||||||
| Stock-based compensation | 1,376 | 1,308 | 1,056 | |||||||||
| Total adjustments to GAAP net loss | 1,376 | 1,308 | 1,056 | |||||||||
| Non-GAAP net loss | $ | (2,380 | ) | $ | (2,705 | ) | $ | (437 | ) | |||
| Depreciation & amortization | 130 | 126 | 102 | |||||||||
| Interest income | (492 | ) | (359 | ) | (115 | ) | ||||||
| Adjusted EBITDA | $ | (2,742 | ) | $ | (2,938 | ) | $ | (450 | ) | |||
| GAAP net loss per share – basic and diluted | $ | (0.19 | ) | $ | (0.22 | ) | $ | (0.09 | ) | |||
| Non-GAAP adjustments | 0.07 | 0.07 | 0.06 | |||||||||
| Non-GAAP net loss per share – basic and diluted | $ | (0.12 | ) | $ | (0.15 | ) | $ | (0.03 | ) | |||
7